3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile

C25H26N8 — CID 146644770

IUPAC3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile
SMILESN#CCCN1[C@@H]2CC[C@H]1CC(Nc1nc(Nc3n[nH]c4ccccc34)cc3ncccc13)C2
InChIInChI=1S/C25H26N8/c26-10-4-12-33-17-8-9-18(33)14-16(13-17)28-24-20-6-3-11-27-22(20)15-23(29-24)30-25-19-5-1-2-7-21(19)31-32-25/h1-3,5-7,11,15-18H,4,8-9,12-14H2,(H3,28,29,30,31,32)/t16?,17-,18+
InChIKeyNWAILFWVCXCQQF-AYHJJNSGSA-N
MW438.54 g/mol
LogP4.57
Rot. Bonds6

About 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile

3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile (PubChem CID 146644770) has the molecular formula C25H26N8 and a molecular weight of 438.54 g/mol. Its IUPAC name is 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile.

Molecular Properties

Compound Name3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile
PubChem CID146644770
Molecular FormulaC25H26N8
Molecular Weight438.54 g/mol
Exact Mass438.23
IUPAC Name3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile
SMILESN#CCCN1[C@@H]2CC[C@H]1CC(Nc1nc(Nc3n[nH]c4ccccc34)cc3ncccc13)C2
InChIInChI=1S/C25H26N8/c26-10-4-12-33-17-8-9-18(33)14-16(13-17)28-24-20-6-3-11-27-22(20)15-23(29-24)30-25-19-5-1-2-7-21(19)31-32-25/h1-3,5-7,11,15-18H,4,8-9,12-14H2,(H3,28,29,30,31,32)/t16?,17-,18+
InChIKeyNWAILFWVCXCQQF-AYHJJNSGSA-N
XLogP4.57
TPSA105.55 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500438.54
LogP ≤ 54.57
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Analyze 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile?
The IUPAC name of 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile (CID 146644770) is 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile.
What is the SMILES notation for 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile?
The canonical SMILES for 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile is N#CCCN1[C@@H]2CC[C@H]1CC(Nc1nc(Nc3n[nH]c4ccccc34)cc3ncccc13)C2.
What is the InChIKey of 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile?
The InChIKey is NWAILFWVCXCQQF-AYHJJNSGSA-N. The full InChI is InChI=1S/C25H26N8/c26-10-4-12-33-17-8-9-18(33)14-16(13-17)28-24-20-6-3-11-27-22(20)15-23(29-24)30-25-19-5-1-2-7-21(19)31-32-25/h1-3,5-7,11,15-18H,4,8-9,12-14H2,(H3,28,29,30,31,32)/t16?,17-,18+.
What are the key properties of 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile?
3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile has a molecular weight of 438.54 g/mol, XLogP of 4.57, 6 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(1R,5S)-3-[[7-(1H-indazol-3-ylamino)-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile is sourced from PubChem (CID 146644770), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).